Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO

Meier, Christian; Uebelhart, Brigitte Florence; Aubry-Rozier, Bérengère; Birkhäuser, Martin; Bischoff-Ferrari, Heike; Frey, Diana; Kressig, Reto W.; Lamy, Olivier; Lippunier, Kurt; Stute, Petra; Suhm, Norbert; Ferrari, Serge Livio

doi:10.4414/smw.2017.14484

Scientific article

English

Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO

ContributorsMeier, Christian; Uebelhart, Brigitte Florence; Aubry-Rozier, Bérengère; Birkhäuser, Martin; Bischoff-Ferrari, Heike; Frey, Diana; Kressig, Reto W.; Lamy, Olivier; Lippunier, Kurt; Stute, Petra; Suhm, Norbert; Ferrari, Serge Livio

Published inSwiss Medical Weekly, vol. 147, no. w14484

Publication date2017

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Génétique des ostéoporoses (544)

Citation (ISO format)

MEIER, Christian et al. Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO. In: Swiss Medical Weekly, 2017, vol. 147, n° w14484. doi: 10.4414/smw.2017.14484

Article (Published version)

Identifiers

PID : unige:99076
DOI : 10.4414/smw.2017.14484

Additional URL for this publicationhttp://doi.emh.ch/smw.2017.14484

Journal ISSN1424-7860

512views

241downloads

Creation09/18/2017 12:18:00 PM

First validation09/18/2017 12:18:00 PM

Update time03/15/2023 2:21:33 AM

Status update03/15/2023 2:21:32 AM

Last indexation10/31/2024 8:35:29 AM

Archive ouverte UNIGE

Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO

Technical informations